|
Mechanismκ opioid receptor agonists [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.TW |
First Approval Date11 Jul 2016 |
评价塞纳布啡长效注射液缓解术后疼痛有效性和安全性的随机、双盲、安慰剂平行对照多中心临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating the efficacy and safety of long-acting senbuphine injection for postoperative pain relief
比较塞纳布啡长效注射液组与安慰剂组术后48小时内吗啡总用量,以评价塞纳布啡长效注射液缓解术后疼痛的有效性。
评价塞纳布啡长效注射液缓解术后疼痛的安全性。
[Translation] The total dosage of morphine within 48 hours after surgery was compared between the senalbuphine long-acting injection group and the placebo group to evaluate the effectiveness of senbuphine long-acting injection in relieving postoperative pain.
To evaluate the safety of senbuphine long-acting injection in relieving postoperative pain.
100 Clinical Results associated with Shanghai Xintan Venture Capital Co., Ltd.
0 Patents (Medical) associated with Shanghai Xintan Venture Capital Co., Ltd.
100 Deals associated with Shanghai Xintan Venture Capital Co., Ltd.
100 Translational Medicine associated with Shanghai Xintan Venture Capital Co., Ltd.